Harvard University and Akonni Biosystems have teamed up to develop and test an amplification array-based diagnostic for multi-drug-resistant and extreme-drug-resistant tuberculosis.

The work is one of several projects that will be supported by a five-year, approximately $29 million Centers of Excellence for Translational Research awarded to Harvard by the National Institute of Allergy and Infectious Diseases to establish a translational research center to develop molecular diagnostic technologies for TB.